CTOs on the Move

Shifamed

www.shifamed.com

 
Shifamed is a Campbell, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.shifamed.com
  • 746 Camden Ave Suite A
    Campbell, CA USA 95008
  • Phone: 408.903.4090

Executives

Name Title Contact Details

Similar Companies

Facey Medical Foundation

Facey Medical Foundation is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Facey Medical Foundation is based in Mission Hills, CA. You can find more information on Facey Medical Foundation at www.facey.com

Affinity Health & Wellness

Affinity Health & Wellness is a medical marijuana dispensary located in New Haven, CT that aims to create a relationship with each patient built on compassion, trust and optimal outcomes.

Zetta Medical Technologies

Zetta Medical Technologies is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Lake Zurich, IL. To find more information about Zetta Medical Technologies, please visit www.zettamed.com

Knox Community Hospital

Knox Community Hospital is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Knox Community Hospital is based in Mount Vernon, OH. You can find more information on Knox Community Hospital at www.knoxcommhosp.org

EyePoint Pharmaceuticals

EyePoint Pharmaceuticals is a pharmaceutical company committed to developing and commercializing therapeutics to help improve the lives of patients with serious eye disorders. The Company`s pipeline leverages its proprietary Durasert® technology for sustained intraocular drug delivery including EYP-1901, a potential six-month intravitreal anti-VEGF treatment initially targeting wet age-related macular degeneration. Durasert`s proven intravitreal drug delivery platform has been safely administered to thousands of patients` eyes across four U.S. FDA-approved products, including YUTIQ® for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye, which is currently marketed by the Company. EyePoint Pharmaceuticals is headquartered in Watertown, Massachusetts.